More well thought out work can be found at — https://axial.substack.com/
Axial partners with great founders and inventors. We invest in early-stage life sciences companies often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you — email us at info@axialvc.com
John Stuelpnagel co-founded Illumina in 1998 as its first CEO. Trained as a biochemist, Stuelpnagel started working on CW Group (Larry Bock’s firm) after getting his MBA at UCLA. While working as a VC, he identified a unique invention out of David Walt’s Lab at Tufts: combining microwell arrays with beads attached to different DNA sequences to enable single nucleotide polymorphisms (SNP) detection. Stuelpnagel was a driving force to build Illumina around what work became their BeadArray platform. This technology quickly became the standard for genome-wide association studies (GWAS), along with Affymetrix, and set the company up to dominate next-generation sequencing — part acquiring Solexa and part out-executing Roche and Thermo. Stuelpnagel is still a leader in the field as chairman of…
